Literature DB >> 33409964

Provisional Stenting for the Treatment of Bifurcation Lesions: In Vitro Insights.

C K Jaryl Ng1,2, Valeria Paradies3, George J Vlachojannis4, Han Wei Toh1,2, Hwa Liang Leo2, E H Philip Wong1,5, Nicolas Foin1,5, Hui Ying Ang6,7.   

Abstract

Provisional stenting is considered the gold standard approach for most bifurcation lesions, but the benefit of routine side branch (SB) strut dilatation has not been fully elucidated. A benchtop model was used to determine the benefits of routine side branch (SB) dilatation techniques on strut apposition, acute thrombogenicity, and flow disruption. Three different provisional bifurcation techniques were compared: no SB dilatation "keep it open" method (KIO), sequential balloon dilatation (SBD), and kissing balloon inflation (KBI). Stents were deployed in a silicon bifurcation model and perfused with blood at a flow rate of 200 ml/min for 60 min. Optical coherence tomography (OCT) pullbacks were obtained before and after flow perfusion to conduct strut analysis and acute thrombus measurement respectively. Computational fluid dynamics (CFD) models were created using OCT pullbacks and simulated based on experimental conditions to analyze flow disruption. The strut analysis showed that KBI had the lowest percentage of floating (10.6 ± 2.3%) (p = 0.0004) and malapposed (41.2 ± 8.5%) struts (p = 0.59), followed by SBD and then KIO. This correlated to KBI having the lowest amount of thrombus formed at the SB, followed by SBD, with KIO being the most thrombogenic (KBI: 0.84 ± 0.22mm2, SBD: 1.17 ± 0.25mm2, KIO: 1.31 ± 0.36mm2, p = 0.18). CFD models also predicted a similar trend, with KBI having the lowest amount of area of high shear rate as well as flow recirculation. Based on this benchtop model, SB intervention strategies demonstrated a reduction in number of struts and resulting thrombogenicity at the bifurcation ostia. Graphical abstract.
© 2021. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Bifurcation; Drug-eluting stent; Stent thrombosis

Mesh:

Year:  2021        PMID: 33409964     DOI: 10.1007/s12265-020-10088-3

Source DB:  PubMed          Journal:  J Cardiovasc Transl Res        ISSN: 1937-5387            Impact factor:   4.132


  3 in total

1.  Impact of final kissing balloon inflation on vessel healing following drug-eluting stent implantation: Insight from the optical coherence tomography sub-study of the J-REVERSE trial.

Authors:  Hachidai Takahashi; Hiromasa Otake; Toshiro Shinke; Yoshinobu Murasato; Yoshihisa Kinoshita; Masahiro Yamawaki; Yoshihiro Takeda; Kenichi Fujii; Shin-Ichiro Yamada; Yoshihisa Shimada; Takehiro Yamashita; Kazuhiko Yumoto; Ken-Ichi Hirata
Journal:  J Cardiol       Date:  2016-02-15       Impact factor: 3.159

2.  Double Kissing Crush Versus Provisional Stenting for Left Main Distal Bifurcation Lesions: DKCRUSH-V Randomized Trial.

Authors:  Shao-Liang Chen; Jue-Jie Zhang; Yaling Han; Jing Kan; Lianglong Chen; Chunguang Qiu; Tiemin Jiang; Ling Tao; Hesong Zeng; Li Li; Yong Xia; Chuanyu Gao; Teguh Santoso; Chootopol Paiboon; Yan Wang; Tak W Kwan; Fei Ye; Nailiang Tian; Zhizhong Liu; Song Lin; Chengzhi Lu; Shangyu Wen; Lang Hong; Qi Zhang; Imad Sheiban; Yawei Xu; Lefeng Wang; Tanveer S Rab; Zhanquan Li; Guanchang Cheng; Lianqun Cui; Martin B Leon; Gregg W Stone
Journal:  J Am Coll Cardiol       Date:  2017-10-30       Impact factor: 24.094

Review 3.  Percutaneous coronary intervention in left main coronary artery disease: the 13th consensus document from the European Bifurcation Club.

Authors:  Francesco Burzotta; Jens Flensted Lassen; Adrian P Banning; Thierry Lefèvre; David Hildick-Smith; Alaide Chieffo; Olivier Darremont; Manuel Pan; Yiannis S Chatzizisis; Remo Albiero; Yves Louvard; Goran Stankovic
Journal:  EuroIntervention       Date:  2018-05-20       Impact factor: 6.534

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.